NEW YORK (GenomeWeb) – Vermillion and Moffitt Cancer Center said yesterday that they are collaborating on a study aimed at generating clinical and economic data to support the use of molecular diagnostics, including Vermillion's OVA1 test, in ovarian cancer care.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene regulation changes linked to human brain evolution, and more.

The New York Stem Cell Foundation's Initiative on Women in Science and Engineering working group presents seven strategies to promote gender equality in the sciences.

Researchers link a genetic variation to the ability to quickly process arsenic in people living in the Andes Mountains.

A small portion of pregnant women who've undergone non-invasive prenatal testing have found out from the test that they have cancer.